3D Model Reveals Secrets of Metastasis

Jul 12, 2006

A cancer cell breaks away from a primary tumor and settles in a new location, where it once again divides. Pharmaceutical companies typically use simplistic two-dimensional assays for this process, which is known as metastasis, to evaluate anti-cancer therapeutics. In these assays, cells crawl across the surface of a matrix, traveling in a single plane. But a new study indicates that this approach misses some crucial phenomena.

Working in the labs of Whitehead Member Paul Matsudaira and MIT professor Douglas Lauffenburger, postdoctoral researcher Muhammad Zaman discovered that cells move quite differently in three dimensions. His study, which focused on human prostate tumor cells, appeared this week in the online early edition of Proceedings of the National Academy of Sciences.

“Two-dimensional assays ignore the obstacles that cells face in their natural contexts,” explains Zaman, who recently became an assistant professor at the University of Texas at Austin. “In 3D, cells move through a thick jungle of fibers, or ‘vines’, that hinder forward progress.”

Cells must either squeeze through or chop up these putative vines to get anywhere. As a result, they move slower in three dimensions.

In an interesting twist, all cells need at least some vines to move, as they latch onto the “branches” with claw-like proteins called integrins and pull themselves forward. When Zaman disabled some of these claws, in a manner analogous to certain anti-cancer drugs, the cells moving across the top of the jungle canopy (in two dimensions) needed a greater number of vines to keep up their pace, while cells plowing through the jungle instead needed vines chopped to maintain the same speed. The complexity of this situation is further increased in that the cells become dramatically sensitive to the stiffness of the vines when the integrins are disabled and consequently tend to squeeze through the vines rather than pushing them aside.

“Our findings help explain why two-dimensional assays for metastasis-inhibiting drugs do not effectively predict their effects in tissue,” says Lauffenburger, who is director of MIT’s Biological Engineering Division. He believes pharmaceutical companies will eventually use three-dimensional assays, accompanied by appropriate computational models such as that also recently published by Zaman (in Biophysical Journal in 2005), to determine how drugs affect metastasis.

But technology must improve before more complicated 3D studies are attempted. For his 3D work Zaman worked with one sample at a time, using a special confocal microscope at the Whitehead-MIT BioImaging Center. The microscope divided each specimen into virtual slices, generating a new stack of images every 15 minutes.

“It took me about a year to get enough data because the microscope wasn’t designed for high-throughput experiments,” he says. Fortunately, the BioImaging Center has one of the most powerful sets of computers at MIT and the imaging processing and analysis went quite quickly.

“Muhammad was successful for two reasons,” says Matsudaira. “His computational model predicted what would happen in virtual experiments and then he was able to go straight to test the predictions with these complicated 3D experiments. As a result, the sophisticated models of cell movement enhance our understanding of key biological processes, including metastasis.”

Source: Whitehead Institute for Biomedical Research

Explore further: Obama offers new accommodations on birth control

add to favorites email to friend print save as pdf

Related Stories

Dinosaur footprints set for public display in Utah

1 hour ago

A dry wash full of 112-million-year-old dinosaur tracks that include an ankylosaurus, dromaeosaurus and a menacing ancestor of the Tyrannosaurus rex, is set to open to the public this fall in Utah.

Fitbit to Schumer: We don't sell personal data

1 hour ago

The maker of a popular line of wearable fitness-tracking devices says it has never sold personal data to advertisers, contrary to concerns raised by U.S. Sen. Charles Schumer.

Dead floppy drive: Kenya recycles global e-waste

1 hour ago

In an industrial area outside Kenya's capital city, workers in hard hats and white masks take shiny new power drills to computer parts. This assembly line is not assembling, though. It is dismantling some ...

Tissue regeneration using anti-inflammatory nanomolecules

1 hour ago

Anyone who has suffered an injury can probably remember the after-effects, including pain, swelling or redness. These are signs that the body is fighting back against the injury. When tissue in the body is damaged, biological ...

Recommended for you

Endogenous hormones improve breast cancer risk models

8 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

With kids in school, parents can work out

8 hours ago

(HealthDay)—Back-to-school time provides an opportunity for parents to develop an exercise plan that fits into the family schedules, an expert suggests.

Ebola death toll rises to 1,427: WHO

8 hours ago

The death toll from the Ebola outbreak sweeping through west African countries has risen to 1,427 out of more than 2,600 cases, the World Health Organization said Friday.

User comments : 0